Al~tract--Murine erythroleukaemia cells (MELC) are erythroid precursor cells that undergo erythroid differentiation in the presence of the inducer hexamethylene bisacetamide (HMBA). The effects of lead on haem biosynthesis in MELC following HMBA-induced differentiation were studied. MELC were induced with HMBA in the presence of 20, 40 and 80/aM-lead acetate and cell density, haem content, incorporation of ~4C-labelled 6-aminolaevulinic acid (ALA) into haem, and the activities of the enzymes 6-aminolaevulinic acid dehydratase (ALA-D), uroporphyrinogen I synthetase (URO-S) and ferrochelatase (FERRO) were determined. MELC exposed to 80/~M-lead showed significant erythroid hypoplasia (40-50%) and a significant decrease (30-50%) in haem content at 2, 4 and 6 days after induction in comparison with the controls. Significant inhibition of ALA-D, the most sensitive index, was noted at 20 ~UM-lead, and at 80/~M-lead ALA-D activity was decreased by 60-80°/, in comparison with the controls. URO-S and FERRO showed significant decreases of 34% and 50%, respectively, at 80/zM-lead. A decrease of 50% in the incorporation of [~4C]ALA into haem at 80/~M-lead indicated an impairment in haem synthesis. The results suggest that the impairment of haem formation by lead is coincident with the production of severe erythroid hypoplasia.
INTRODUCTION
Lead has long been known to exert toxic effects on the erythropoietic system that are associated with the development of anaemia. There is little information available concerning the regulation of haem biosynthesis in the bone marrow associated with the development of anaemia following exposure to lead. Most previous studies concerning the aetiology of drug/toxicant-associated anaemia and its relationship to the biosynthesis of haem have been conducted with the mature red blood cell, which is not actively engaged in haem synthesis. Therefore, more relevant information is likely to be obtained by focusing study on the bone marrow rather than the red blood cell. Furthermore, controlled study of the role of various physiological (hormonal, nutritional) factors that regulate haem synthesis and/or influence the development of lead-or drug-associated anaemias is lacking. It is known that lead is preferentially deposited in bone marrow, and its concentration may reach 50 times that in blood (Albahary, 1972) . Consequently, bone marrow cells, particularly premature erythroid precursor cells, are most susceptible to the toxic effects of lead which can result in an anaemia characterized by erythroid hypoplasia (Sassa, 1978) . *To whom correspondence should be addressed. Abbreviations: ALA = 6-aminolaevulinic acid; ALA-D = 6-aminolaevulinic acid dehydratase; BPb = blood lead concentration; DTT = dithiothreitol; FERRO = ferrochelatase, HMBA = hexamethylene bisacetamide; MELC = murine erythroleukaemia cells; MEM = minimum essential medium; PBG =porphobilinogen; PBGase = porphobilinogen deaminase; PBS = phosphate buffered saline; URO-S=uroporphyrinogen ! synthetase.
The haem biosynthetic pathway in erythroid tissue is a well known target for the toxic effects of lead (Bottomley and Muller-Eberhard, 1988) . Lead has been shown to inhibit virtually all the enzymes of the pathway. 6-Aminolaevulinic acid dehydratase (ALA-D) is most sensitive to lead in vitro and in vivo, followed by ferrochelatase (FERRO), coproporphyrinogen oxidase and porphobilinogen deaminase (PBGase, uroporphyrinogen I synthetase), respectively. Very high lead concentrations inhibit uroporphyrinogen decarboxylase and di-aminolaevulinic acid synthase (Bottomley, 1977) .
As a result of the complex cellular heterogeneity of bone marrow in vivo, controlled study of this cellular target in the whole animal is rather difficult. Therefore, an in vitro system was used to study lead interactions and regulation of haem synthesis in erythroid precursor cells. The relative ease with which conditions can be manipulated in vitro makes it possible to study the role of various hormonal and nutritional factors that may regulate haem synthesis and/or influence the development of lead-or drugassociated anaemias.
Murine erythroleukaemia cells (MELC) are a continuous cell line of erythroid precursor cells which, in the presence of certain chemicals such as dimethylsulphoxide and hexamethylene bisacetamide (HMBA), undergo changes similar to the normal maturation of red blood cells (Friend et al., 1971; Reuben et al., 1976) . These changes include alterations in morphology, sequential induction of enzymes in the haem biosynthetic pathway with the production of haem and haemoglobin, expression of carbonic anhydrase activity, and the appearance of spectrin and red blood cell surface antigens (Marks and Rifkind, 1978) . It is anticipated that MELC will be a useful in citro model to study drug/toxicant interactions during erythropoiesis.
In the studies described here we investigated the effects of lead on haem biosynthesis in MELC following HMBA-induced erythroid differentiation. The studies were designed to assess the ability of lead to (I) impair haem formation through a disruption in the normal maturation process and/or perturbation of selected enzymes m the haem biosynthetic pathway, and (2) to produce a state of erythroid hypoplasia in differentiating MELC).
MATERIALS AND METHODS
Cell culture. The murine erythroleukaemia cell line, clone 745A, derived from the DBA/2 mouse, was obtained from the NIGMS Human Genetic Mutant Cell Repository, Institute for Medical Research, (Camden, N J, USA). Cells were seeded at a final density of 5 x 105cells/ml in spinner flasks. Spinner cultures were maintained in an incubator at 37~C in medium consisting of Iscove's modified Dulbecco's minimum essential medium (MEM); Boehringer Mannheim Biochemicals, Indianapolis, IN, USA) supplemented with 5% (v/v) defined bovine calf serum (Hyclone Laboratories Inc., Logan, UT, USA). Induction of differentiation was achieved by addition of a stock solution (250mM) of HMBA (Sigma Chemical Co.. St Louis, MO, USA) to a final medium concentration of 3 raM. To assess the effects of lead, MELC were induced to differentiate in the continuous presence of 0 (control), 20, 40 or 80 p~-lead by appropriate freshly prepared dilutions in medium of a stock lead acetate solution in distilled deionized water (10 mM). Lead concentrations were chosen on the basis of solubility limits in culture medium and cell viability (trypan blue exclusion) during exposure periods. The actual lead concentrations in medium were 19.5, 38.7 and 77.2pM as determined by atomic absorption spectrophotometry (Chemical Pathology, Department of Pathology, Medical School, University of Michigan, MI, USA). The lead concentration in control medium was below the limits of detection. Under all conditions, cell viability was >90%. Cultures were split every other day to 5 x 105cells/ml by dilution in fresh MEM containing HMBA and lead where appropriate.
Unless stated otherwise, the following parameters were determined 2, 4 and 6 days after induction,' exposure as described below.
Cell density and benzidine staining. Cell density was carried out using a haemocytometer. Cell doubling time was measured according to the method described by Patterson (1979) . The percentage of haemoglobin-containing cells was determined at 6 days by benzidine staining according to the method of Gopalakrishnan and Anderson (1979) . A minimum of 500 cells were evaluated for each condition.
Haem content. Haem content was measured by the microfluorometric method of Sassa (1976) . Briefly, cell pellets were rinsed in phosphate buffered saline (PBS; pH 7.45) and heated in 2 M-oxalic acid for 30 min at 100°C. Hemin (Sigma Chemical Co.) served as a standard and was heated similarly. After cooling, fluorescence was determined on an Aminco-Bowman Spectrophotofluorometer (American Instrument Co. Inc., Silver Spring, MD, USA).
Subcellular fractionation. At the indicated times, MELC were collected by centrifugation at 100g for 10min and rinsed with PBS. The washed cell pellets (from control and lead-exposed MELC) were weighed and resuspended in three volumes of ice-cold distilled deionized water to lyse cells. These suspensions were homogenized manually with 15 strokes in a glass-teflon homogenizer and then adjusted to pH 7.8 by the addition of six volumes of 50 mM-Tris-HCI (pH 8.0). The homogenate was centrifuged at 800g for 15min to remove cellular debris. The resulting supernatant was centrifuged at 9000g for 20 min, yielding a mitochondrial pellet. This mitochondrial pellet, washed and resuspended in 50 mMTris-HCl (pH 7.4), served as the enzyme source. The resulting 9000-g supernatant was centrifuged at 100,000g for 60min to form the cytosolic fraction and the microsomal pellet. The cytosolic fraction served as the enzyme source. Protein content was determined by the method of Lowry et al. (1951) using bovine serum albumin as standard.
Activities of haem biosynthetic enzymes. The activity of ALA-D was measured in MELC cytosol by the method of Gibson et al. (1955) . The product, porphobilinogen (PBG), was measured spectrophotometrically (553 nm) after reaction with Ehrlich's reagent (Mauzerall and Granick, 1956 ). Spectrophotometric determination of PBG was carried out on an SLM Aminco DW-2000 UV-VIS Spectrophotometer (SLM Instruments Inc., Urbana, IL, USA) using a millimolar extinction coefficient of 61.
Cytosolic uroporphyrinogen I synthetase (URO-S) was measured by a modification (Sassa et al., 1974) of the method of Strand et al. (1972) . The cytosolic preparation was incubated with 100/~M-PBG (Porphyrin Products, Logan, UT, USA) in 50 mM-Tris-HCI-50 mr, l-KC1 (pH 7.8) at 37 C for 45 min. The reaction was terminated by cooling tubes on ice and immediately adding ethyl acetate-acetic acid (2: 1, v/v). Then 1.0 N-HCI was added and the mixture was shaken vigorously. The phases were allowed to separate and stand for 30 min in room light. The porphyrin fluorescence in the lower aqueous phase was determined and compared to a uroporphyrin I standard (Porphyrin Products) using a spectrophotoftuorometer.
Mitochondrial FERRO activity was measured by the pyridine haemochromagen method described by Dailey (1986) . The assay measures the formation of deuterohaem from deuteroporphyrin IX (Porphyrin Products). Deuterohaem was quantitated by reduced minus oxidized difference spectra of its pyridine haemochrome by UV-visible spectrophotometry. For deuterohaem, a millimolar extinction coefficient (545-530 nm) of 15.3 was used.
Microsomal haem oxygenase. Microsomal haem oxygenase activity was measured according to the method described by Tenhunen et al. (1968) .
Uroporphyrin I and III isomer composition. The composition of uroporphyrin isomers formed in the URO-S assay was analysed by HPLC as described by Rideout et al. (1983) . Separations were carried out on a Waters Associates (Model 6000A) solvent delivery system interfaced to a Schoeffel (Model FS 970) fluorometer equipped with a C18 bonded column (spherical 5/~m, 4.6-ram diameter x 22crn) from Brownlee Labs (Santa Clara, CA, USA), The mobile phase was 13% (v/v) acetonitrile in 1 M-ammonium acetate buffer (pH 5.16).
DNA synthesis. DNA synthesis was measured as described by Friend et al. (1987) . Cells were pulse labelled with [rnethyl-~H] thymidine (0.5 #Ci/ml; New England Nuclear, Boston, MA, USA) for l hr at 37°C at 1, 3 and 5 days after induction/exposure (logphase growth). The incorporation of [~H] thymidine into the acid insoluble fraction of cells was determined by precipitation with 10% trichloroacetic acid at 5cC and collection of precipitates on Whatman 3MM filter paper squares. Radioactivity was determined by liquid scintillation spectrometry.
Incorporation of [s4C]ALA into haem.
Incorporation of ~4C-labelled 6-aminolaevulinic acid (ALA) into haern was measured by a modification of the method of Bonkowsky (1978) . Cells were incubated with [~4C]ALA (0.17/aCi/ml; Amersham, Arlington Heights, IL, USA) for 24hr at 37°C. Cell pellets (8 × 106 cells) were reconstituted with ethyl acetateacetic acid (4: 1, v/v; ferrous sulphate washed) with 1 raM-heroin (Sigma Chemical Co.) added as carrier, and extracted with distilled deionized water and 1 r~-HCI. ~4C radioactivity in the dried ethyl acetate residue (haem phase) was determined in a Beckman LS8000 scintillation spectrometer using Scinti-Verse BD (Fisher Scientific, Fair Lawn, N J, USA) as counting scintillant. The percentage recovery of carrier bemin was determined by the pyridine haemochromogen method (Falk, 1964 ) and found to be > 80% for both control and lead-treated cultures.
Statistics. Student's t-test was used to compare differences in mean values between control and leadexposed MELC cultures.
RESULTS

Cell density and benzidine staining
MELC cultures exposed to 80/aM-lead showed significant erythroid hypoplasia (40--50% decreases in cell density) at 2, 4 and 6 days after induction/ exposure (Fig. 1 ). Cells were also greatly enlarged in comparison with control MELC, with cell lysis evident (data not shown). Average cell doubling time was also significantly increased at this lead concentration for all three time periods (18.36 + 2.02 hr for controls v. 28.04 + 1.86 hr for 80#M-lead exposed, P < 0.01). Cellular haemoglobin content was estimated by benzidine staining. Only MELC cultures exposed to 80 itM-lead showed a significant decrease (58% of control) in the percentage of benzidine positive cells at 6 days after induction/exposure (84.3 + 2.4% for controls v. 48.8 + 6.8% for 80/~ra-lead exposed, P < 0.01).
naem content
There was a progressive accumulation of haemoglobin-associated haem in control MELC after HMBA induction (Fig. 2) . Only MELC exposed to 80/aM-lead failed to show appreciable accumulation of haem over the 6-day period. In comparison with controls, there was a significant decrease in haem content in MELC exposed to 80/aM-lead at 2, 4 and 6 days after induction/exposure and a slight but significant decrease in those exposed to 40 #M-lead at 6 days.
DNA synthesis
There was a significant decrease (30-40%) in [3H]thymidine incorporation in MELC exposed to 80/au-lead at I, 3 and 5 days after induction/ exposure (Table 1) Haemoglobin-associated haem content was determined at 2, 4 and 6 days after induction/ exposure. Each bar represents the mean + SEM from nine determinations and asterisks denote significant difference (Student's t-test) from the corresponding control value (*P < 0.01; **P < 0.001). Values are the means ~ SEM from three determinations, and those marked with an asterisk differ significantly (Student's t-test) from the corresponding control value (*P < 0.05).
perturbations in cell density (Fig. 1) and cell doubling time. ALA-D = 6-aminolaevulinic acid dehydratase DTT = dithiothreitol PBG = porphobilinogen DTT and ZnCI 2 were added at concentrations of 16 and 0.1 mM, respectively. Values are means -r-SEM for three determinations and those marked with asterisks differ significantly (Student's t-test) from the control value (*P < 0.001).
Activities of haem biosynthetic enzymes and composition of uroporphyrin isomers
Increases in the activities of the haem biosynthetic enzymes ALA-D, URO-S and FERRO were observed in control MELC following HMBA induction (Sassa, 1976) , with maximum levels of activity attained at day 4 for ALA-D and URO-S and at day 6 for FERRO (Table 2) . Following lead exposure, all three enzymes showed varying degrees of reduced activity in comparison with controls. A significant decrease (30-40%) in ALA-D activity, by far the most sensitive index of lead exposure, was noted at 20 and 40/aM-lead and only 20-40% of control activity was observed for MELC exposed to 80 pM-lead. The profound inhibition in ALA-D activity noted at 80pM-lead could be reversed by reactivation using zinc and dithiothreitol (DTT) in the assay incubation (Table 3) as reported by others (Finelli et al., 1975; Geisse et al., 1983; Tzukamoto et al., 1979) . URO-S activity was significantly depressed (66% of control activity) only after exposure to 80 pM-lead and at 4 days after induction. MELC exposed to 40 or 80 pMlead showed no significant differences from controls in the proportions of uroporphyrin I and Ill isomers formed in the URO-S assay (Fig. 3) . A significant decrease (50--60% of control activity) in FERRO was observed only in MELC exposed to 80pM-lead. 
Microsomal haem oxygenase
The activity of microsomal haem oxygenase was found to be non-detectable and non-inducible by lead exposure in MELC (data not shown).
Incorporation of [14C]ALA into haem
The effect of lead exposure on haem synthesis was investigated by measurement of [~4C]ALA incorporation into haem. Maximum levels of [~4C]ALA incorporation into haem were observed in control MELC between day 3 and day 5 after HMBA induction (Fig. 4) ALA into haem at 24-hr intervals between day I and day 5 was measured as described in Materials and Methods. Values represent the mean incorporation + SEM from four determinations, and an asterisk denotes a significant difference (Student's t-test) from the corresponding control value (*P < 0.001).
with the lack of appreciable haem accumulation noted for this lead concentration (Fig. 2) .
DISCUSSION
Previous studies of erythropoiesis using bone marrow cells in t'itro have been complicated by the contamination of the erythroid cellular component with myeloid and stromal elements and the lack of adequate control over the maturation program of erythroid precursors (Allen and Dexter, 1983; Dexter, 1979) . MELC are a clonal cell line of erythroid precursors whose maturation program can be controlled by the addition of soluble polar chemicals such as dimethylsulphoxide or HMBA (Marks and Rifkind, 1978) and we have used them to study the effects of lead on erythroid cell growth and maturation and the synthesis of haem.
The results showed a significant decrease in the accumulation of haemoglobin-associated haem only in MELC exposed to 80 pM-lead following induction of differentiation with HMBA. However, this decrease in haem content was accompanied by cell enlargement, cell lysis and significant erythroid hypoplasia, with subsequent disruptions in DNA synthesis and cell doubling time. The data demonstrated that the impairment by lead of haem formation in MELC was coincident with the production of a severe erythroid hypoplasia with haemolytic changes.
With respect to cases of human lead exposure, it is rather difficult to assess the relationship between the concentration of lead required to impair haem synthesis in this in vitro system with that which might be attainable in humans, by either general or occupational exposure, because most of the data for humans are expressed in terms of lead concentration in blood (BPb), not in bone marrow, although bone marrow is the major site of haem synthesis. It has been estimated that the concentration of lead in bone and marrow is 50-80 times that in the blood (Albahary, 1972; Baloh, 1974; Flood et al., 1988; Gross et al., 1975) , with normal BPb levels ranging between 20 and 40/~g/100 ml. However, a subsequent long-term survey has revealed that BPb levels in US adults have been declining to a value of around 10 pg/100 ml (Annest, 1983) . In cases of occupational lead poisoning, BPb values may exceed 80/~g/100 ml (Brangstrup Hansen et al., 1981) . Lead in bone and marrow is distributed among the cellular components (erythroid precursors, myelocytes, granulocytes) as well as the mineralized bone matrix itself. Recent studies using laser microbeam mass analysis to assess lead distribution on the subcellular level suggest that lead is three to ten times more concentrated in nuclei than in the cytoplasm of bone marrow cells (Flood et al., 1988) . Using the data obtained from an individual with severe lead poisoning, a crude estimation of the concentration of lead in the cytoplasm of all bone marrow cell types lies between 20 and 60/aM. Unfortunately, Ca-EDTA chelation therapy had commenced in this individual before the measurements were taken. In the in vitro system described here, only the erythroid cellular component of marrow was exposed to lead. Thus, until further data become available, it remains uncertain whether the erythroid element of bone marrow in vivo would be exposed to the concentration of lead that was required to impair haem synthesis in this in ritro system.
The effect of lead exposure on haem formation in MELC was determined by evaluating the activities of selected enzymes in the haem synthetic pathway and the incorporation of [~4C]ALA into haem. In the haem synthetic pathway, the activity of ALA-D was most sensitive to lead, followed by FERRO and URO-S, respectively, with the latter two showing significant decreases only at 80/aM-lead. A significant depression in the activity of ALA-D has been reported in rat whole bone marrow cell suspensions with exposure to as low as 0.5/z M-lead (Dresner et al., 1982) . However, it is difficult to compare their results with ours because of the differences both in lead exposure conditions and methods of cell culture. No effect of lead exposure was noted in the proportion of uroporphyrinogen I and III isomers formed in the URO-S assay. Levels of haem were depressed only under conditions in which the activities of all three enzymes studied were decreased. Furthermore, decreases in the activity of ALA-D of up to 50% could occur without any significant decrease in haem content. This observation is analogous to that in humans. ALA-D activity is negatively correlated with BPb concentration in the general population (Lolin and O'Gorman, 1986; Secchi and Alessio, 1974; Waldron, 1974) , and is impaired by BPb levels well within the range of values found in individuals with only environmental exposure. It is believed that since the reserve capacity of ALA-D is large, its inhibition at low BPb levels is not likely to interfere with haem synthesis (Waldron, 1974) .
It has been suggested that lead's effect on haem synthesis most probably involves interference with a number of enzymes in the haem synthetic pathway. In humans, decreases in erythrocyte URO-S are not often observed in lead poisoning (Campbell et al., 1977; El-Waseef, 1982) , although lead-associated decreases are observed when 5-aminolaevulinic acid is used as substrate rather than porphobilinogen (El-Waseef, 1982; Ford et al., 1980) , suggesting that substrate deprivation through inhibition of ALA-D plays a role in impairing subsequent synthesis of uroporphyrinogen. Using porphobilinogen as substrate, URO-S showed the least extent of inhibition by lead in the in vitro system described here, with no effect on the composition of uroporphyrinogen isomers formed. The relative lack of sensitivity of uroporphyrinogen synthesis to lead inhibition may be explained by the fact that, in this system as well as in liver, this step is well protected by a low-molecularweight, heat-stable factor (Ku and Piper, 1990; Piper and van Lier, 1977) .
The activity of FERRO was significantly affected by the highest concentration of lead used in our /n t'itro system. In lead poisoning in humans, profound depression in the activity of FERRO, measured by either the percentage of 59Fe uptake into haem or the level of erythrocyte protoporphyrin, has been observed (Campbell et al., 1977; Lubran, 1980; Piomelli et al., 1982; Rogan et al., 1986) . As for other enzymes in the haem synthetic pathway, Campbell et al. (1977) reported marked elevation of ALA synthase, normal uroporphyrinogen decarboxylase and depressed coproporphyrinogen oxidase as common features of lead poisoning in addition to the enzyme changes previously mentioned. In our in t'itro system, the activities of these enzymes were not determined.
The question may be raised as to whether increases in haem catabolism could explain the decrease in haem content at 80/~M-lead. However, haem oxygenase activity was found to be extremely low and non-inducible by lead exposure in MELC. Furthermore, a lead-associated disruption in the ability to synthesize haem was confirmed by the decreased incorporation of [~4C]ALA into haem that was noted in MELC exposed to 80/~M-lead.
Overall, the data are consistent with the suggestion that a lead-associated disruption in haem synthesis involves interference with a number of enzymes in the haem synthetic pathway, and that this disruption is accompanied and complicated by severe erythroid hypoplasia. Apart from the question of the lead concentrations used, the in vitro system described here provides a useful model to study the regulation of haem synthesis, isomer composition of haem intermediates, and drug/toxicant interactions during erythropoiesis. Furthermore, by manipulation of the tissue culture environment, it is possible to identify the role of various hormonal and nutritional factors that regulate haem synthesis and/or influence the development of lead-or drug-associated anaemia. In our laboratory, a major interest is the role of polyglutamated folate derivatives that protect against inhibition of URO-S by lead (Ku and Piper, 1990; Piper and van Lier, 1977) . Most importantly, the use of the MELC technique to evaluate the potential of commercial and/or therapeutic products to impair haem formation and/or interfere with normal erythroid development should refine conditions to study the basic underlying mechanism of action in the absence of complicating factors encountered in rivo.
